Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Inflammation × Gastrointestinal × Clear all

Phase

Phase NA 12 Phase 4 3 Phase EARLY_PHASE1 2 Phase 1 2 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 401 Pancreatic Neoplasms 319 Stomach Neoplasms 219 Carcinoma, Hepatocellular 203 Carcinoma, Non-Small-Cell Lung 145 Colonic Neoplasms 129 Esophageal Neoplasms 122 Ovarian Neoplasms 99 Neoplasms 99 Rectal Neoplasms 94 Neoplasm Metastasis 88 Liver Neoplasms 87 Breast Neoplasms 87 Lung Neoplasms 67 Melanoma 66 Squamous Cell Carcinoma of Head and Neck 62 Carcinoma, Renal Cell 51 Gastrointestinal Neoplasms 49 Endometrial Neoplasms 48 Biliary Tract Neoplasms 47 Head and Neck Neoplasms 46 Uterine Cervical Neoplasms 45 Triple Negative Breast Neoplasms 42 Cholangiocarcinoma 42 Sarcoma 41 Prostatic Neoplasms 38 Esophageal Squamous Cell Carcinoma 36 Urinary Bladder Neoplasms 31 Carcinoma 27 Small Cell Lung Carcinoma 24

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02759601 2018-12-20

CHR-2845

Queen Mary University of London

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡